Since a direct link has been demonstrated between inflammatory diseases of the skin, associated with chronic inflammation such as psoriasis, with atherosclerosis, and of cardiovascular diseases [39,40,41], we also used a keratinocyte model, in which a psoriatic phenotype has been induced with IL-22 treatment [12,13]. Here, IL22 is linked to cardiovascular disorder.